Viktoria Zaderer

Innsbruck, 6020, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Aloe-derived polysaccharides (APS) mitigate SARS-CoV-2 Omicron BQ1.1 infection by preserving epithelial integrity and reducing viral load in human airway epithelial (HAE) cultures.

Aloe-derived polysaccharides (APS) mitigate SARS-CoV-2 Omicron BQ1.1 infection by preserving epithelial integrity and reducing viral load in human airway epithelial (HAE) cultures.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 10, 2025

The Role of Enoxaparin in Influenza Virus Infections and its Therapeutic Implications.

The Role of Enoxaparin in Influenza Virus Infections and its Therapeutic Implications.

Journal: The Journal of infectious diseases
Published: May 28, 2025

Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variant.

Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variant.

Journal: Molecular therapy. Nucleic acids
Published: September 26, 2024

Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern.

Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern.

Journal: Microbiology spectrum
Published: August 08, 2023

Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epithelia.

Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epithelia.

Journal: Frontiers in immunology
Published: July 13, 2023

P80 natural essence spray and lozenges provide respiratory protection against Influenza A, B, and SARS-CoV-2.

P80 natural essence spray and lozenges provide respiratory protection against Influenza A, B, and SARS-CoV-2.

Journal: Respiratory research
Published: July 13, 2023

Correction: ColdZyme® protects airway epithelia from infection with BA.4/5.

Correction: ColdZyme® protects airway epithelia from infection with BA.4/5.

Journal: Respiratory research
Published: January 24, 2023

GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events.

GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events.

Journal: Respiratory research
Published: December 23, 2022

Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation.

Antiviral drugs block replication of highly immune-evasive Omicron subvariants ex vivo, but fail to reduce tissue inflammation.

Journal: Antiviral research
Published: November 25, 2022

Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2.

Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2.

Journal: mBio
Published: November 03, 2022

ColdZyme® protects airway epithelia from infection with BA.4/5.

ColdZyme® protects airway epithelia from infection with BA.4/5.

Journal: Respiratory research
Published: August 23, 2022

Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections.

Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections.

Journal: Frontiers in medicine
Published: July 28, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026